July 10, 2018
1 min read
Save

BHVI partners with SynergEyes

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SynergEyes has announced a new partnership with Brien Holden Vision Institute to offer new designs on the hybrid contact lens platform to help correct myopia and presbyopia.

“SynergEyes seeks to improve the quality of life for people by delivering on the hybrid platform innovative lens designs that solve age-old problems in a new way,” James Kirchner, OD, president and CEO of SynergEyes, said in a press release from the institute. “Working with a recognized worldwide leader like the Brien Holden Vision Institute, we plan to bring an extended depth-of-focus [EDOF] lens design onto the hybrid platform to the global market.

According to the release, the licensing agreement will allow design technologies – such as extended depth of focus – developed by Brien Holden Vision Institute (BHVI) to be manufactured, adding to the SynergEyes presbyopic package to deliver contact lenses with precise correction and comfort. Eye care professionals will be able to offer patients with myopia and presbyopia tailored hybrid contact lenses that provide clear vision from all distances with minimal ghosting. BHVI’s extended depth of focus design technology can manipulate multiple higher-order aberrations by providing smooth, non-monotonic power variation across the optic zone. This extension offers balanced vision to presbyopes with low, medium and high add requirements, according to the release.

“We are delighted to be partnering with SynergEyes to bring our novel EDOF designs in myopia and presbyopia management in specialty hybrid contact lenses and make them available to a broader market around the world,” BHVI CEO Kovin Naidoo, OD, PhD, said in the release. “This is especially important for myopia, as our mission is to slow the progression of myopia in all children to reduce their risk of permanent vision impairment and address a looming public health crisis.”